[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355724-105":59,"doc-detail-355724-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clonal-relationship-in-a-rare-pulmonary-mixed-tumor-shared-alk-fusion-in-atypical-carcinoid-and-adenocarcinoma-a-case-report","Clonal relationship in a rare pulmonary mixed tumor - shared ALK fusion in atypical carcinoid and adenocarcinoma - a case report","","Rare pulmonary mixed neuroendocrine and non-neuroendocrine neoplasm (MiNEN) is usually classified as combinations involving high-grade neuroendocrine carcinomas, while NSCLC coexisting with typical or atypical carcinoid is not recognized and remains poorly understood. This case report describes a 62-year-old man whose MiNEN contained both atypical carcinoid and adenocarcinoma. Distinct components shared a KIF5B-ALK fusion and identical PMS1, PXDNL, TMEM132C, and NQO1 mutations, supporting a monoclonal origin. Findings suggest potential shared molecular drivers and responsiveness to targeted ALK inhibition.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clonal-relationship-in-a-rare-pulmonary-mixed-tumor-shared-alk-fusion-in-atypical-carcinoid-and-adenocarcinoma-a-case-report/355724/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clonal-relationship-in-a-rare-pulmonary-mixed-tumor-shared-alk-fusion-in-atypical-carcinoid-and-adenocarcinoma-a-case-report/355724.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What rare pulmonary tumor type is discussed in the case report?","Question",{"text":112,"@type":113},"The report focuses on pulmonary mixed neuroendocrine and non-neuroendocrine neoplasm (MiNEN) containing an atypical carcinoid component and an invasive adenocarcinoma component.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What molecular evidence supports a clonal (monoclonal) relationship between the tumor components?",{"text":117,"@type":113},"Next-generation sequencing found a shared KIF5B-ALK gene fusion in both components, and both also carried identical mutations in PMS1, PXDNL, TMEM132C, and NQO1.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical implications do the authors suggest?",{"text":121,"@type":113},"The findings suggest that MiNEN-associated carcinoids may share molecular drivers with NSCLC and may be responsive to targeted therapies such as ALK inhibitors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355724,1790563239,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Case Report  \nClonal relationship in a rare pulmonary mixed tumor: shared ALK fusion in atypical carcinoid and adenocarcinoma—a case report  \nKyoung Min Kim1,2,3, Jong Hun Kim4, Myoung Ja Chung1,2,3  \n1Department of Pathology, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Jeollabuk, Republic of Korea; 2Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk, Republic of Korea; 3Institute for Medical Sciences of Jeonbuk National University, Jeonju, Jeollabuk, Republic of Korea; 4Department of Thoracic and Cardiovascular Surgery, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Jeollabuk, Republic of Korea  \nContributions: (I) Conception and design: MJ Chung, KM Kim; (II) Administrative support: JH Kim; (III) Provision of study materials or patients: JH Kim, KM Kim; (IV) Collection and assembly of data: MJ Chung, KM Kim; (V) Data analysis and interpretation: MJ Chung, KM Kim; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Prof. Myoung Ja Chung, MD, PhD. Department of Pathology, Jeonbuk National University Hospital, Jeonbuk National University Medical School, 567 Baekje-daero, Doekjin-gu, Jeonju-si, Jeollabuk-do 54907, Republic of Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk, Republic of Korea; Institute for Medical Sciences of Jeonbuk National University, Jeonju, Jeollabuk, [Republic of Korea. Email: mjchung@jbnu.ac.kr](Republic of Korea. Email: mjchung@jbnu.ac.kr).  \nBackground: Pulmonary mixed neuroendocrine and non-neuroendocrine neoplasms (MiNENs) are currently described in the World Health Organization (WHO) classification primarily as combinations of non-small cell lung cancer (NSCLC) and high-grade neuroendocrine carcinomas, such as small cell lung cancer (SCLC) or large cell neuroendocrine carcinoma (LCNEC) . The coexistence of NSCLC with typical or atypical carcinoid (TC/AC) tumors is not officially recognized in the current classification and remains an exceptionally rare entity, with limited information on its pathogenesis. We sought to delineate the molecular  \nalterations underlying a rare case ofMiNEN composed of AC and adenocarcinoma.  \nCase Description: A 62-year-old male with a history of prostate cancer underwent a right apical segmentectomy for a suspicious lung nodule detected on follow-up computed tomography (CT) . Theresected 1.4 cm tumor was histologically diagnosed as a MiNEN, comprising an AC component (60%) and a well-differentiated invasive adenocarcinoma component (40%) . Next-generation sequencing (NGS) performed on the distinct components identified a KIF5B-ALK gene fusion shared by both theneuroendocrine and adenocarcinoma elements. Furthermore, both components harbored identical mutations in the PMS1, PXDNL, TMEM132C, and NQO1 genes. ALK immunohistochemistry confirmed strong, diffuse cytoplasmic positivity in both tumor populations. The identification of a shared ALK rearrangement and overlapping mutational profiles in morphologically distinct components strongly supports a monoclonal  \norigin from a common progenitor cell, rather than a collision of independent tumors.  \nConclusions: These findings suggest that MiNEN-associated carcinoids may share molecular drivers with NSCLC, distinct from the genetic landscape of sporadic carcinoids, and may be responsive to targeted therapies such as ALK inhibitors. Expanding the current WHO classification to include these low-grade neuroendocrine combinations is warranted to facilitate better diagnostic definition and clinical management.  \nKeywords: Adenocarcinoma; mixed neuroendocrine and non-neuroendocrine neoplasm (MiNEN); next  \ngeneration sequencing (NGS); ALK; case report  \nSubmitted De","cbCaig6NgmsGHjsK","https://ap.wps.com/l/cbCaig6NgmsGHjsK","pdf",3668300,11,"English","# Background\n## Case Description\n## Conclusions","[{\"question\":\"What rare pulmonary tumor type is discussed in the case report?\",\"answer\":\"The report focuses on pulmonary mixed neuroendocrine and non-neuroendocrine neoplasm (MiNEN) containing an atypical carcinoid component and an invasive adenocarcinoma component.\"},{\"question\":\"What molecular evidence supports a clonal (monoclonal) relationship between the tumor components?\",\"answer\":\"Next-generation sequencing found a shared KIF5B-ALK gene fusion in both components, and both also carried identical mutations in PMS1, PXDNL, TMEM132C, and NQO1.\"},{\"question\":\"What clinical implications do the authors suggest?\",\"answer\":\"The findings suggest that MiNEN-associated carcinoids may share molecular drivers with NSCLC and may be responsive to targeted therapies such as ALK inhibitors.\"}]","Clonal relationship in a rare pulmonary mixed tumor - shared ALK fusion in atypical carcinoid and adenocarcinoma - a case report | PDF",1790120646,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/484c639276cbd557b4b6815e16035b7c.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5b914925f736535df642d9f9091a3ba.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83639ee626749b6840330df678e67c24.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6711c636450def6318f2d2cee3694cc7.webp",980,1283]